NSE SYNCOMFMain boardPharmaceuticals

Syncom Formulations (India) Limited

Pharmaceuticals · Updated 14 Oct 2026

Observed activity6.4/10Moderate observable activity

Share price₹22.3Market cap ₹2,096 Cr

Syncom Formulations (India) Limited overview

Digital presence

The official website syncomformulations.com was reviewed on 14 Oct 2026 and uses HTTPS, is mobile-friendly, has an investor relations section.

A LinkedIn page was found with 2,700 followers and a company size band of 1K-5K, latest 1 hour ago.

A Facebook page was found with 4,800 followers, latest post 1 hour ago.

Sub-brands noted

Cratus (Life Care, Evolve, Right Nutrition)

Information not available

LinkedIn posts in 90 days: not captured
Instagram page: not found
Facebook posts in 90 days: not captured
LinkedIn employee count: not captured
X account: not found
YouTube channel: not found

Presence Radar

Reviewed 14 Oct 2026

Website 6LinkedIn 7Instagram n/aFacebook 6

Moderate observable activity. Colour shows the level of observed activity: higher, moderate, limited. Not a judgement of the company. Methodology v0. How it works

Website

6/10

syncomformulations.com

Website checks

✓HTTPSYes

✓Mobile friendlyYes

✓Investor relations sectionPresent

–Footer copyright year2024

?Mobile page speed (0–100)Not captured

Market snapshot prototype data

52-week low
₹10.252-week high
₹27.5

Price₹22.3

Market cap₹2,096 Cr

All-time high₹27.5

Below all-time high18.9%

P/E24.7

Promoter holding50.57%

Dividend yield0.45%

Source: research sheet (14 Oct 2026). Market data still needs a licensed source before public launch.

More in Pharmaceuticals

Accent Microcell LimitedNSE ACCENTMICHigher

Prototype data. Details may be incomplete or out of date. Verify with official filings and exchange disclosures.